Skip to content

A prospective, randomized control study of retrograde artery first approach pancreatosplenectomy versus radical antegrade modular pancreaticosplenectomy for pancreatic cancer

A prospective, randomized control study of retrograde artery first approach pancreatosplenectomy versus radical antegrade modular pancreaticosplenectomy for pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065457
Enrollment
Unknown
Registered
2022-11-04
Start date
2022-11-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

RAFAPS group:Retrograde artery first approach pancreatosplenectomy
Control group:radical antegrade modular pancreaticosplenectomy

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years (inclusive), regardless of gender; 2. Patients who meet the surgical indications and plan to undergo laparoscopic or robotic radical splenectomy of the pancreatic body and tail; 3. ASA grade I-III; 4. Patients and family members can understand the study protocol and are willing to participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of major upper abdominal surgery, such as splenectomy, gastrectomy, liver resection, duodenectomy, colectomy or pancreatectomy, excluding laparoscopic cholecystectomy; 2. History of abdominal and pelvic radiotherapy; 3. Patients receiving neoadjuvant chemotherapy for abdominal malignant tumors; 4. Pancreatic trauma; 5. Severe organ dysfunction of heart, lung, liver, kidney and other organs and intolerant to surgery.

Design outcomes

Primary

MeasureTime frame
The rate of successful surgical completion;

Secondary

MeasureTime frame
Intraoperative and postoperative safety and efficiency indicators;Short-term oncology indicators;

Countries

China

Contacts

Public ContactTian Feng

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

andytianfeng@126.com+86 10 69152602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026